Full Paper
NMR (101 MHz, CDCl ): δ = 164.3 (Cq), 163.4 (Cq), 162.2 (Cq), 141.9
2005, 7, 4753–4756; b) M. Cheung, P. A. Harris, J. G. Badiang, G. E. Peck-
ham, S. D. Chamberlain, M. J. Alberti, D. K. Jung, S. S. Harris, N. H. Bram-
son, A. H. Epperly, S. A. Stimpson, M. R. Peel, Bioorg. Med. Chem. Lett.
2008, 18, 5428–5430.
4] T. Koike, T. Takai, Y. Hoashi, M. Nakayama, Y. Kosugi, M. Nakashima, S.-i.
Yoshikubo, K. Hirai, O. Uchikawa, J. Med. Chem. 2011, 54, 4207–4218.
5] H. Tamta, S. Kalra, A. K. Mukhopadhyay, Biochemistry (Mosc.) 2006, 71,
S49–54.
6] A. Kulkarni, P. Quang, V. Curry, R. Keyes, W. Zhou, H. Cho, J. Baffoe, B.
Török, K. Stieglitz, Chem. Biol. Drug Des. 2014, 84, 270–281.
7] A. H. Abdelazeem, S. A. Abdelatef, M. T. El-Saadi, H. A. Omar, S. I. Khan,
C. R. McCurdy, S. M. El-Moghay, Eur. J. Pharm. Sci. 2014, 62, 197–211.
8] a) P. Dinér, J. P. Alao, J. Söderlund, P. Sunnerhagen, M. Grøtli, J. Med.
Chem. 2012, 55, 4872–4876; b) J. Y. Le Brazidec, A. Pasis, B. Tam, C. Boy-
kin, C. Black, D. Wang, G. Claassen, J. H. Chong, J. Chao, J. Fan, K. Nguyen,
L. Silvian, L. Ling, L. Zhang, M. Choi, M. Teng, N. Pathan, S. Zhao, T. Li, A.
Taveras, Bioorg. Med. Chem. Lett. 2012, 22, 2070–2074; c) J. Kaplan, J. C.
Verheijen, N. Brooijmans, L. Toral-Barza, I. Hollander, K. Yu, A. Zask, Bioorg.
Med. Chem. Lett. 2010, 20, 640–643.
3
2
(Cq), 141.5 (Cq), 140.2 (Cq), 135.5 (Cq), 132.1 (q, JC,F3 = 32.0 Hz, Cq),
1
1
2
29.9 (CH ), 129.8 (2 × CH ), 129.4 (2 × CH ), 129.0 (2 × CH ),
Ar Ar Ar Ar
3
1
26.5 (CH ), 125.3 (q, J
= 4.0 Hz, 2 × CH ), 124.4 (q, J
=
Ar
C,F3
Ar
C,F3
[
[
[
[
[
73.0 Hz, Cq), 120.1 (CH ), 118.6 (CH ), 103.8 (Cq), 21.7 (CH ) ppm.
Ar
Ar
3
HRMS (ESI): calcd. for C23H16F3N4 [M + H]+ 405.1322; found
4
05.1320.
4
-[4-(p-Tolyl)pyrido(1′,2′:1,5)pyrazolo[3,4-d]pyrimidin-2-yl]-
benzonitrile (33): From 17 with 4-cyanophenylboronic acid as the
coupling reagent and by general procedure D, 33 was isolated as a
yellow solid in 64 % yield after purification by silica gel flash chro-
matography (petroleum ether/EtOAc, 4:6), m.p. 263–264 °C. R (pe-
f
troleum ether/EtOAc, 4:6) = 0.55. IR (ATR diamond): ν˜ = 2921, 2221,
–
1 1
1
634, 1557, 1509, 1433, 1266, 1117, 978, 801, 752 cm . H NMR
(
400 MHz, CDCl ): δ = 8.97 (d, J = 6.8 Hz, 1 H), 8.89 (d, J = 8.0 Hz,
3
2
8
H), 8.19 (d, J = 8.8 Hz, 1 H), 7.95 (d, J = 8.0 Hz, 2 H), 7.80 (d, J =
.0 Hz, 2 H), 7.57 (t, J = 8.8 Hz, 1 H), 7.48 (d, J = 8.0 Hz, 2 H), 7.42
1
3
[9] R. Belaroussi, A. El Bouakher, M. Marchivie, S. Massip, C. Jarry, A. El Hak-
(t, J = 6.8 Hz, 1 H), 2.54 (s, 3 H) ppm. C NMR (101 MHz, CDCl3):
maoui, G. Guillaumet, S. Routier, M. Akssira, Synthesis 2013, 45, 2557–
δ = 164.3 (Cq), 163.3 (CN), 161.5 (Cq), 142.7 (Cq), 141.6 (Cq), 135.6
2
566.
(
Cq), 135.2 (Cq), 132.2 (2 × CH), 129.9 (CH ), 129.8 (2 × CH ), 129.5
Ar Ar
[10] a) O. Dehbi, A. Tikad, S. Bourg, P. Bonnet, O. Lozach, L. Meijer, M. Aadil,
M. Akssira, G. Guillaumet, S. Routier, Eur. J. Med. Chem. 2014, 80, 352–
363; b) A. Tikad, O. Dehbi, M. Akssira, M. Aadil, S. Massip, J. M. Leger, C.
Jarry, G. Guillaumet, S. Routier, Synthesis 2013, 45, 491–500; c) A. Tikad,
M. Akssira, S. Massip, J. M. Leger, C. Jarry, G. Guillaumet, S. Routier, Eur.
J. Org. Chem. 2012, 4523–4532; d) A. Tikad, S. Routier, M. Akssira, G.
Guillaumet, Org. Biomol. Chem. 2009, 7, 5113–5118; e) A. Tikad, S. Rou-
tier, M. Akssira, J. M. Leger, C. Jarry, G. Guillaumet, Synthesis 2009, 2379–
2284; f) A. Tikad, S. Routier, M. Akssira, J. M. Leger, C. Jarry, G. Guillaumet,
Org. Lett. 2007, 9, 4673–4676; g) A. Tikad, S. Routier, M. Akssira, J. M.
Leger, C. Jarry, G. Guillaumet, Synlett 2006, 1938–1942.
[11] a) M. Redondo, J. G. Zarruk, P. Ceballos, D. I. Pérez, C. Pérez, A. Perez-
Castillo, M. A. Moro, J. Brea, C. Val, M. I. Cadavid, M. I. Loza, N. E. Campillo,
A. Martínez, C. Gil, Eur. J. Med. Chem. 2012, 47, 175–185; b) A. Castro,
M. J. Jerez, C. Gil, F. Calderon, T. Domenech, A. Nueda, A. Martinez, Eur.
J. Med. Chem. 2008, 43, 1349–1359; c) Z. Li, H. Huang, H. Sun, H. Jiang,
H. Liu, J. Comb. Chem. 2008, 10, 484–486.
(
2 × CH ), 128.9 (2 × CH ), 126.7 (CH ), 120.1 (CH ), 119.1 (Cq),
Ar Ar Ar Ar
1
18.8 (CHAr),113.7 (Cq), 103.7 (Cq), 21.7 (CH ) ppm. HRMS (ESI):
3
+
calcd. for C H N [M + H] 362.1400; found 362.1399.
23 16 5
2
-(Pyridin-3-yl)-4-(p-tolyl)pyrido[1′,2′:1,5]pyrazolo[3,4-d]pyr-
imidine (34): From 17 with 3-pyridinylboronic acid as the coupling
reagent and by general procedure D, 34 was isolated as a yellow
solid in 44 % yield after purification by silica gel flash chromatogra-
phy (petroleum ether/EtOAc, 4:6), m.p. 238–239 °C. R (petroleum
f
ether/EtOAc, 4:6) = 0.05. IR (ATR diamond): ν˜ = 2919, 1634, 1533,
–
1
1
1
434, 1357, 1273, 1128, 1023, 834, 801, 714 cm . H NMR (400 MHz,
CDCl ): δ = 9.96 (s, 1 H), 9.02 (d, J = 8.8 Hz, 1 H), 8.96 (d, J = 6.8 Hz,
3
1
7
2
H), 8.74 (s, 1 H), 8.18 (d, J = 8.8 Hz, 1 H), 7.97 (d, J = 8.0 Hz, 2 H),
.56 (t, J = 8.8 Hz, 1 H), 7.52–7.42 (m, 3 H), 7.40 (t, J = 6.8 Hz, 1 H),
.54 (s, 3 H) ppm. 1 C NMR (101 MHz, CDCl ): δ = 164.4 (Cq), 163.4
3
3
(
Cq), 161.8 (Cq), 151.2 (CH ), 150.8 (CH ), 142.6 (Cq), 141.5 (Cq),
Ar Ar
[12] D. R. Guda, T. Wang, H. M. Cho, M. E. Lee, Tetrahedron Lett. 2012, 53,
5238–5242.
1
36.4 (Cq), 135.6 (Cq), 135.4 (CH ), 129.9 (CH ), 129.8 (2 × CH ),
Ar Ar Ar
1
29.0 (2 × CH ), 126.6 (CH ), 123.4 (CH ), 120.1 (CH ), 118.6
[13] A. Santagati, J. Longmore, S. Guccione, T. Langer, E. Tonnel, M. Modica,
M. Santagati, L. M. Scolaro, F. Russo, Eur. J. Med. Chem. 1997, 32, 973–
985.
Ar
Ar
Ar
Ar
(CH ), 103.6 (Cq), 21.7 (CH ) ppm. HRMS (ESI): calcd. for C H N
Ar 3 21 16 5
+
[
M + H] 338.1400; found 338.1400.
[
14] a) S.-M. Li, J. Huang, G.-J. Chen, F.-S. Han, Chem. Commun. 2011, 47,
2840–12842; b) F.-A. Kang, Z. Sui, W. V. Murray, J. Am. Chem. Soc. 2008,
Supporting Information (see footnote on the first page of this
article): H, C, and C DEPT NMR spectra for all compounds.
1
1
13
13
130, 11300–11302; c) C. Shi, C. C. Aldrich, Org. Lett. 2010, 12, 2286–2289;
d) V. P. Mehta, S. G. Modha, E. V. Van der Eycken, J. Org. Chem. 2010, 75,
9
76–979; e) A. Sharma, D. Vachhani, E. Van der Eycken, Org. Lett. 2012,
Acknowledgments
14, 1854–1857.
[
15] a) F.-A. Kang, Z. Sui, W. V. Murray, Eur. J. Org. Chem. 2009, 461–479; b) J.
Coste, E. Frerot, P. Jouin, J. Org. Chem. 1994, 59, 2437–2446; c) E. Frérot,
J. Coste, A. Pantaloni, M.-N. Dufour, P. Jouin, Tetrahedron 1991, 47, 259–
The authors acknowledge the Office Mediterranéen de la Jeu-
nesse (OMJ) for financial support to R. B.
2
70; G.-J. Chen, J. Huang, L.-X. Gao, F.-S. Han, Chem. Eur. J. 2011, 17,
4
038–4042.
Keywords: Synthesis design · Cross-coupling · Nucleophilic
substitution · Nitrogen heterocycles · Palladium
[
16] F.-A. Kang, J. Kodah, Q. Guan, X. Li, W. V. Murray, J. Org. Chem. 2005, 70,
1957–1960.
[
17] a) Q. Sun, F. Suzenet, G. Guillaumet, J. Org. Chem. 2010, 75, 3473–3476;
b) M. Egi, L. S. Liebeskind, Org. Lett. 2003, 5, 801–802; c) F. A. Alphonse,
F. Suzenet, A. Keromnes, B. Lebret, G. Guillaumet, Synlett 2002, 447–450;
d) F. A. Alphonse, F. Suzenet, A. Keromnes, B. Lebret, G. Guillaumet, Org.
Lett. 2003, 5, 803–805; e) L. S. Liebeskind, J. Srogl, Org. Lett. 2002, 4,
979–981; f) H. Prokopcov, O. Kappe, Angew. Chem. Int. Ed. 2009, 48,
2276–2286; Angew. Chem. 2009, 121, 2312.
[
[
[
1] A. Akahane, H. Katayama, T. Mitsunaga, T. Kato, T. Kinoshita, Y. Kita, T.
Kusunoki, T. Terai, K. Yoshida, Y. Shiokawa, J. Med. Chem. 1999, 42, 779–
783.
2] B. A. Johns, K. S. Gudmundsson, E. M. Turner, S. H. Allen, V. A. Samano,
J. A. Ray, G. A. Freeman, F. L. Boyd Jr., C. J. Sexton, D. W. Selleseth, K. L.
Creech, K. R. Moniri, Bioorg. Med. Chem. 2005, 13, 2397–2411.
3] a) K. L. Stevens, D. K. Jung, M. J. Alberti, J. G. Badiang, G. E. Peckham,
J. M. Veal, M. Cheung, P. A. Harris, S. D. Chamberlain, M. R. Peel, Org. Lett.
Received: March 22, 2016
Published Online: July 4, 2016
Eur. J. Org. Chem. 2016, 3550–3558
www.eurjoc.org
3558
© 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim